Lipocine, Inc. (LPCN)
2.37
-0.02
(-0.84%)
USD |
NASDAQ |
May 08, 16:00
2.37
0.00 (0.00%)
After-Hours: 20:00
Lipocine Shareholders Equity (Quarterly) : 22.83M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 93.95M |
| Verrica Pharmaceuticals, Inc. | 24.74M |
| Corcept Therapeutics, Inc. | 637.99M |
| Johnson & Johnson | 81.19B |
| Eli Lilly & Co. | 31.20B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.36M |
| Total Liabilities (Quarterly) | 2.528M |
| Current Ratio | 9.987 |